FARICIMAB

FARICIMAB was reported 8868 times

FARICIMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 OPTICAL COHERENCE TOMOGRAPHY ABNORMAL 776 0.9023
1 OPTICAL COHERENCE TOMOGRAPHY 15 0.8824
2 RETINAL THICKENING 1471 0.8808
3 VISUAL ACUITY TESTS ABNORMAL 346 0.6223
4 CORNEAL ENDOTHELIAL MICROSCOPY 1 0.5000
5 PERIPHERAL EXUDATIVE HAEMORRHAGIC CHORIORETINOPATHY 2 0.4000
6 ANAEMIC RETINOPATHY 1 0.3333
7 RETINAL OCCLUSIVE VASCULITIS 66 0.2946
8 MACULAR THICKENING 22 0.2619
9 KERATIC PRECIPITATES 99 0.2084
10 OCULAR VASCULITIS 36 0.2081
11 SUBRETINAL HYPERREFLECTIVE EXUDATION 5 0.1852
12 FLUORESCENCE ANGIOGRAM ABNORMAL 2 0.1818
13 MONOCULAR VISION 2 0.1538
14 HAEMORRHAGIC OCCLUSIVE RETINAL VASCULITIS 11 0.1507
15 VITRITIS 269 0.1452
16 RADIATION RETINOPATHY 3 0.1304
17 COMPUTER VISION SYNDROME 1 0.1250
18 ANTERIOR CHAMBER INFLAMMATION 70 0.1176
19 IDIOPATHIC ORBITAL INFLAMMATION 22 0.1146
20 VITREAL CELLS 23 0.1139
21 RETINAL PIGMENT EPITHELIAL TEAR 76 0.1095
22 UVEITIC GLAUCOMA 4 0.1053
23 OPTIC DISC VASCULAR DISORDER 2 0.1053
24 CEREBRAL MICROINFARCTION 6 0.1034
25 ANGIOGRAM RETINA ABNORMAL 3 0.1000
26 CILIARY ZONULAR DEHISCENCE 1 0.0909
27 INTRA-OCULAR INJECTION COMPLICATION 20 0.0881
28 CORNEAL ENDOTHELIITIS 8 0.0833
29 KERATOUVEITIS 3 0.0811
30 IRIDOCYCLITIS 244 0.0771
31 ANGIOGRAM PERIPHERAL ABNORMAL 1 0.0769
32 HYALOSIS ASTEROID 3 0.0732
33 VITREOUS HAZE 11 0.0719
34 SUBRETINAL FIBROSIS 14 0.0718
35 CYCLITIC MEMBRANE 1 0.0714
36 NONINFECTIVE CHORIORETINITIS 2 0.0667
37 CONJUNCTIVAL RETRACTION 1 0.0625
38 PSEUDOENDOPHTHALMITIS 6 0.0606
39 ANTERIOR CHAMBER FLARE 14 0.0601
40 DELLEN 1 0.0588
41 CENTRAL VISION LOSS 13 0.0583
42 PSEUDOPHAKIA 5 0.0575
43 CHORIORETINITIS 36 0.0558
44 VITREOUS DEGENERATION 9 0.0549
45 RETINAL VASCULITIS 64 0.0537
46 ANTERIOR SEGMENT ISCHAEMIA 1 0.0526
47 CHOROIDAL HAEMORRHAGE 10 0.0518
48 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 72 0.0515
49 BLEPHARAL PAPILLOMA 1 0.0500
50 VITREOUS OPACITIES 42 0.0497
51 ANTERIOR CHAMBER DISORDER 11 0.0478
52 EPIRETINAL MEMBRANE 13 0.0468
53 SUBRETINAL FLUID 51 0.0467
54 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 40 0.0449
55 SUBRETINAL HAEMATOMA 2 0.0444
56 ENDOPHTHALMITIS 266 0.0443
57 HYPOPYON 35 0.0423
58 CORNEAL STRIAE 3 0.0423
59 CULTURE NEGATIVE 1 0.0417
60 AQUEOUS HUMOUR LEAKAGE 1 0.0417
61 POSTERIOR CAPSULE OPACIFICATION 14 0.0408
62 NON-INFECTIOUS ENDOPHTHALMITIS 34 0.0400
63 INTRAOCULAR HAEMATOMA 2 0.0400
64 ANTERIOR CHAMBER CELL 28 0.0392
65 EYE INFLAMMATION 360 0.0377
66 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 43 0.0345
67 OPTIC DISC OEDEMA 4 0.0345
68 BACTERIAL ENDOPHTHALMITIS 9 0.0338
69 DIABETIC RETINAL OEDEMA 17 0.0335
70 IRITIS 99 0.0325
71 OCULAR MELANOMA 2 0.0323
72 EPIGLOTTIC CANCER 1 0.0312
73 CORNEAL DECOMPENSATION 5 0.0311
74 VIRAL UVEITIS 3 0.0309
75 RETINAL HAEMORRHAGE 202 0.0283
76 CYCLITIS 1 0.0270
77 EYE NAEVUS 3 0.0263
78 UVEITIS 353 0.0260
79 INTRAOCULAR PRESSURE TEST 6 0.0250
80 VITREOUS DISORDER 12 0.0248
81 VITREOUS FLOATERS 239 0.0243
82 MENINGORRHAGIA 6 0.0240
83 IRIS NEOVASCULARISATION 3 0.0240
84 HYPOTONY OF EYE 10 0.0238
85 VISUAL ACUITY REDUCED TRANSIENTLY 7 0.0227
86 RETINOSCHISIS 3 0.0217
87 OCULAR STROKE 3 0.0216
88 DUCHENNE MUSCULAR DYSTROPHY 2 0.0215
89 RETINAL OEDEMA 41 0.0214
90 VITREORETINAL TRACTION SYNDROME 2 0.0211
91 CHOROIDAL NEOVASCULARISATION 18 0.0210
92 CORNEAL BLEEDING 2 0.0208
93 RETINAL DEGENERATION 27 0.0208
94 MACULAR SCAR 4 0.0206
95 OCULAR HYPERTENSION 40 0.0206
96 RETINAL VASCULAR OCCLUSION 15 0.0203
97 TOXIC ANTERIOR SEGMENT SYNDROME 22 0.0202
98 RETINAL ANEURYSM 4 0.0200
99 RETINAL ISCHAEMIA 12 0.0196
100 RETINAL PERIVASCULAR SHEATHING 2 0.0194
101 POLYPOIDAL CHOROIDAL VASCULOPATHY 6 0.0194
102 EYE ABRASION 1 0.0189
103 INTERCEPTED PRODUCT STORAGE ERROR 67 0.0188
104 CONJUNCTIVAL BLEB 1 0.0185
105 VITREOUS HAEMORRHAGE 51 0.0184
106 RETINAL VEIN OCCLUSION 52 0.0181
107 PAPILLITIS 3 0.0179
108 ACUTE MACULAR NEURORETINOPATHY 3 0.0175
109 CORNEAL PIGMENTATION 1 0.0175
110 PANOPHTHALMITIS 3 0.0164
111 RETINAL EXUDATES 15 0.0160
112 RETINAL NEOVASCULARISATION 4 0.0159
113 CONJUNCTIVAL CYST 1 0.0156
114 RETINAL VASCULAR DISORDER 9 0.0154
115 HAEMORRHAGIC VASCULITIS 2 0.0153
116 EYE HAEMATOMA 4 0.0152
117 CHOROIDAL DETACHMENT 8 0.0144
118 HEREDITARY OPTIC ATROPHY 1 0.0143
119 COMBINED PULMONARY FIBROSIS AND EMPHYSEMA 1 0.0141
120 CORNEAL OEDEMA 31 0.0138
121 HISTOLOGY ABNORMAL 3 0.0136
122 DRY AGE-RELATED MACULAR DEGENERATION 15 0.0135
123 CATARACT NUCLEAR 9 0.0135
124 RETINAL ARTERY OCCLUSION 33 0.0130
125 SCLERAL HAEMORRHAGE 3 0.0130
126 RETINAL DRUSEN 2 0.0122
127 INTRAOCULAR PRESSURE INCREASED 155 0.0121
128 RETINAL CYST 2 0.0120
129 KERATOSIS PILARIS 3 0.0120
130 VITRECTOMY 7 0.0117
131 LENTICULAR OPACITIES 5 0.0114
132 INTRAOCULAR PRESSURE DECREASED 6 0.0114
133 ARTERIOSCLEROTIC RETINOPATHY 1 0.0110
134 NO ADVERSE EVENT 1970 0.0109
135 METAMORPHOPSIA 20 0.0108
136 CILIARY HYPERAEMIA 1 0.0105
137 OCULAR PROCEDURAL COMPLICATION 2 0.0103
138 ISCHAEMIC ENTERITIS 1 0.0103
139 RETINOPATHY PROLIFERATIVE 2 0.0103
140 HERNIA PERFORATION 1 0.0102
141 CYSTOID MACULAR OEDEMA 19 0.0101
142 VISUAL ACUITY REDUCED 332 0.0100
143 AGE-RELATED MACULAR DEGENERATION 15 0.0099
144 CORNEAL EXFOLIATION 1 0.0098
145 DIABETIC RETINOPATHY 33 0.0097
146 MACULAR HOLE 13 0.0097
147 FUNDOSCOPY ABNORMAL 1 0.0096
148 RHEGMATOGENOUS RETINAL DETACHMENT 2 0.0096
149 OPTIC DISC DISORDER 2 0.0095
150 CORNEAL ABSCESS 1 0.0093
151 CORNEAL INFECTION 2 0.0092
152 PRESBYOPIA 5 0.0090
153 THERMAL BURNS OF EYE 2 0.0088
154 OPTIC DISC HAEMORRHAGE 2 0.0087
155 RETINITIS 15 0.0087
156 IVTH NERVE PARALYSIS 2 0.0084
157 CHARLES BONNET SYNDROME 1 0.0083
158 CANDIDA ENDOPHTHALMITIS 1 0.0082
159 OPEN ANGLE GLAUCOMA 5 0.0081
160 ANTERIOR CHAMBER FIBRIN 1 0.0078
161 HYPHAEMA 4 0.0077
162 EYE COMPLICATION ASSOCIATED WITH DEVICE 2 0.0074
163 CORNEAL EROSION 4 0.0074
164 FOREIGN BODY IN EYE 7 0.0073
165 RETINAL DISORDER 19 0.0073
166 EPISCLERITIS 5 0.0072
167 SUDDEN VISUAL LOSS 2 0.0072
168 SEROUS RETINAL DETACHMENT 6 0.0072
169 MACULAR OEDEMA 40 0.0071
170 EYE HAEMORRHAGE 95 0.0071
171 CRUSH SYNDROME 1 0.0071
172 OPHTHALMIC HERPES SIMPLEX 4 0.0069
173 VISUAL IMPAIRMENT 856 0.0069
174 SCLERITIS 11 0.0069
175 DERMATOCHALASIS 1 0.0068
176 BLINDNESS 275 0.0067
177 CATARACT CORTICAL 1 0.0067
178 RETINAL DEPIGMENTATION 2 0.0065
179 NECROTISING RETINITIS 4 0.0063
180 OPTIC NERVE INJURY 7 0.0060
181 PERIORBITAL PAIN 5 0.0059
182 CENTRAL SEROUS CHORIORETINOPATHY 4 0.0059
183 EYELID BLEEDING 1 0.0058
184 BLINDNESS UNILATERAL 78 0.0055
185 OPTIC ATROPHY 9 0.0055
186 INADEQUATE ASEPTIC TECHNIQUE IN USE OF PRODUCT 2 0.0055
187 CARDIOLIPIN ANTIBODY POSITIVE 1 0.0055
188 BORDERLINE GLAUCOMA 1 0.0054
189 CORNEAL DEPOSITS 4 0.0054
190 CHOROIDITIS 2 0.0053
191 FOREIGN BODY SENSATION IN EYES 34 0.0053
192 RETINAL TEAR 13 0.0053
193 CORNEAL OPACITY 7 0.0051
194 CHORIORETINAL DISORDER 1 0.0051
195 CHOROIDAL EFFUSION 4 0.0050
196 EYE EXCISION 1 0.0049
197 OCULAR VASCULAR DISORDER 4 0.0048
198 CORNEAL DYSTROPHY 2 0.0048
199 CORNEAL GRAFT REJECTION 1 0.0048
200 INFERIOR VENA CAVA DILATATION 1 0.0047
201 AUTOINFLAMMATORY DISEASE 1 0.0047
202 RETINAL PIGMENT EPITHELIOPATHY 2 0.0046
203 MYOPIA 11 0.0046
204 VITREOUS DETACHMENT 10 0.0046
205 CORNEAL DISORDER 10 0.0046
206 EYE OEDEMA 11 0.0045
207 DIABETIC EYE DISEASE 2 0.0044
208 CARDIAC PERFORATION 1 0.0043
209 RETINAL SCAR 2 0.0043
210 INTRAOCULAR PRESSURE TEST ABNORMAL 3 0.0043
211 CONJUNCTIVAL HAEMORRHAGE 16 0.0042
212 RETINAL DETACHMENT 38 0.0041
213 ILLNESS ANXIETY DISORDER 1 0.0041
214 CORNEAL NEOVASCULARISATION 1 0.0040
215 EYE DISORDER 131 0.0040
216 GLAUCOMA SURGERY 1 0.0039
217 GLARE 2 0.0039
218 IRIS ADHESIONS 2 0.0039
219 CONJUNCTIVAL OEDEMA 4 0.0039
220 CORNEAL THINNING 1 0.0039
221 RETINAL INJURY 3 0.0039
222 DENTURE WEARER 1 0.0039
223 VASCULITIS 45 0.0039
224 RETINAL VASCULAR THROMBOSIS 2 0.0038
225 HERPES OPHTHALMIC 5 0.0038
226 ARTERIOVENOUS FISTULA OPERATION 1 0.0037
227 CHEMICAL BURNS OF EYE 1 0.0036
228 EYE INFECTION BACTERIAL 2 0.0036
229 EXCESSIVE SKIN 1 0.0035
230 DIABETIC GANGRENE 1 0.0035
231 CREUTZFELDT-JAKOB DISEASE 1 0.0035
232 CORNEAL EPITHELIUM DEFECT 2 0.0034
233 EYE PAIN 194 0.0034
234 AMBLYOPIA 2 0.0034
235 OFF LABEL USE 2963 0.0034
236 KERATITIS 10 0.0033
237 CATARACT SUBCAPSULAR 2 0.0033
238 IMMUNE-MEDIATED ADVERSE REACTION 5 0.0033
239 BREAST INFLAMMATION 1 0.0032
240 CORNEAL LESION 1 0.0032
241 VASCULAR RUPTURE 5 0.0032
242 CORNEAL INFILTRATES 1 0.0032
243 MACULAR DEGENERATION 38 0.0032
244 CORNEAL PERFORATION 2 0.0032
245 PHOTOPSIA 20 0.0032
246 HYPERMETROPIA 3 0.0032
247 ATROPHY 6 0.0031
248 GLAUCOMA 58 0.0030
249 EYE INFECTION 34 0.0030
250 IODINE ALLERGY 1 0.0030
251 ANION GAP DECREASED 1 0.0029
252 BLINDNESS TRANSIENT 21 0.0028
253 DIALYSIS RELATED COMPLICATION 1 0.0028
254 AUDITORY DISORDER 4 0.0028
255 EYE SYMPTOM 1 0.0028
256 CHEMICAL POISONING 1 0.0027
257 HEPATIC INFARCTION 1 0.0027
258 VITH NERVE PARALYSIS 3 0.0026
259 READING DISORDER 6 0.0026
260 FIBROSIS 8 0.0026
261 EYELID FUNCTION DISORDER 2 0.0025
262 PRODUCT CONTAMINATION 9 0.0025
263 GLYCOSYLATED HAEMOGLOBIN DECREASED 4 0.0025
264 DEVICE COLOUR ISSUE 1 0.0025
265 CULTURE POSITIVE 2 0.0024
266 CORONARY ARTERY DISSECTION 2 0.0023
267 EYELID INFECTION 1 0.0023
268 DEGENERATIVE BONE DISEASE 1 0.0023
269 MACULOPATHY 8 0.0023
270 PHOTOPHOBIA 42 0.0022
271 VISUAL FIELD DEFECT 16 0.0022
272 VENOUS OCCLUSION 4 0.0022
273 PUNCTATE KERATITIS 2 0.0022
274 INFLAMMATION 112 0.0022
275 ABNORMAL SENSATION IN EYE 9 0.0021
276 BRAIN STEM STROKE 1 0.0020
277 INTRAOCULAR LENS IMPLANT 1 0.0020
278 ASTIGMATISM 3 0.0020
279 BRAIN STEM INFARCTION 2 0.0020
280 BRAIN NEOPLASM BENIGN 1 0.0020
281 INJURY CORNEAL 1 0.0019
282 ASPARTATE AMINOTRANSFERASE DECREASED 1 0.0019
283 LACRIMATION INCREASED 57 0.0019
284 OPTIC NERVE DISORDER 3 0.0019
285 OCULAR DISCOMFORT 21 0.0019
286 EYE DISCHARGE 19 0.0018
287 INTERLEUKIN LEVEL INCREASED 1 0.0018
288 BLOOD INSULIN INCREASED 1 0.0018
289 HYPERTENSIVE URGENCY 1 0.0018
290 VISION BLURRED 245 0.0018
291 CATARACT 103 0.0017
292 HYPOAESTHESIA EYE 1 0.0017
293 CYANOPSIA 1 0.0017
294 SWELLING OF EYELID 10 0.0016
295 EPSTEIN-BARR VIRUS TEST POSITIVE 1 0.0016
296 ARTERITIS 1 0.0016
297 OPTIC ISCHAEMIC NEUROPATHY 6 0.0015
298 ALLERGIC OEDEMA 1 0.0015
299 DRUG DELIVERY SYSTEM ISSUE 3 0.0015
300 EYE OPERATION 7 0.0015
301 ACUTE LEFT VENTRICULAR FAILURE 1 0.0015
302 HEAT ILLNESS 1 0.0015
303 EYELID PAIN 3 0.0015
304 INFLAMMATORY PAIN 1 0.0015
305 CYST RUPTURE 1 0.0015
306 CORNEAL ABRASION 2 0.0015
307 OCULAR HYPERAEMIA 68 0.0014
308 EYE CONTUSION 3 0.0014
309 CEREBELLAR HAEMORRHAGE 2 0.0014
310 NOROVIRUS INFECTION 2 0.0014
311 VASCULAR INJURY 2 0.0014
312 ALANINE AMINOTRANSFERASE DECREASED 1 0.0014
313 CHROMATOPSIA 1 0.0013
314 EYE INJURY 4 0.0013
315 ISCHAEMIA 6 0.0013
316 INTERCEPTED MEDICATION ERROR 6 0.0013
317 INFECTION PARASITIC 1 0.0013
318 ASTHENOPIA 7 0.0013
319 ENDOCARDITIS BACTERIAL 1 0.0013
320 INTERMITTENT CLAUDICATION 2 0.0013
321 LIMB DEFORMITY 2 0.0013
322 NIGHT BLINDNESS 2 0.0012
323 PERIORBITAL SWELLING 7 0.0012
324 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL 1 0.0012
325 DYSBIOSIS 1 0.0012
326 INJECTION RELATED REACTION 2 0.0012
327 GIANT CELL ARTERITIS 1 0.0012
328 CAMPYLOBACTER INFECTION 1 0.0012
329 SYRINGE ISSUE 21 0.0012
330 CEREBRAL VENOUS SINUS THROMBOSIS 1 0.0012
331 LOWER RESPIRATORY TRACT CONGESTION 2 0.0012
332 CRANIOFACIAL FRACTURE 1 0.0012
333 PRODUCT TEMPERATURE EXCURSION ISSUE 6 0.0012
334 CONJUNCTIVAL HYPERAEMIA 4 0.0011
335 ULCERATIVE KERATITIS 3 0.0011
336 SUSPECTED PRODUCT QUALITY ISSUE 2 0.0011
337 COLOUR BLINDNESS 1 0.0011
338 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0011
339 ANGIOPATHY 6 0.0011
340 DRY EYE 53 0.0011
341 BRAIN STEM HAEMORRHAGE 1 0.0011
342 TUMOUR HAEMORRHAGE 3 0.0011
343 EYE IRRITATION 60 0.0010
344 HERPES VIRUS INFECTION 6 0.0010
345 DRUG ADMINISTERED IN WRONG DEVICE 1 0.0010
346 BLEPHARITIS 4 0.0010
347 FALSE POSITIVE INVESTIGATION RESULT 1 0.0010
348 EYE COLOUR CHANGE 1 0.0010
349 CEREBRAL INFARCTION 24 0.0010
350 DIABETIC FOOT 3 0.0010
351 LEG AMPUTATION 4 0.0010
352 EYELIDS PRURITUS 3 0.0010
353 BLOOD SODIUM ABNORMAL 1 0.0009
354 INNER EAR DISORDER 1 0.0009
355 ANTINUCLEAR ANTIBODY POSITIVE 3 0.0009
356 BLADDER DILATATION 1 0.0009
357 GASTROINTESTINAL TRACT IRRITATION 1 0.0009
358 EYE SWELLING 34 0.0009
359 DIABETIC NEPHROPATHY 2 0.0009
360 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 1 0.0009
361 DIVERTICULUM INTESTINAL HAEMORRHAGIC 2 0.0009
362 GRANULOMA 3 0.0009
363 HYPERTENSIVE EMERGENCY 1 0.0008
364 BLEEDING TIME PROLONGED 1 0.0008
365 HAEMATOLOGICAL INFECTION 2 0.0008
366 AORTIC VALVE REPLACEMENT 1 0.0008
367 DEMENTIA 22 0.0008
368 ANGLE CLOSURE GLAUCOMA 2 0.0008
369 MEAN CELL VOLUME INCREASED 2 0.0008
370 PERIPHERAL VASCULAR DISORDER 4 0.0008
371 INTERCEPTED PRODUCT SELECTION ERROR 1 0.0008
372 HYPOVITAMINOSIS 1 0.0008
373 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 2 0.0008
374 INTRACRANIAL ANEURYSM 3 0.0007
375 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 3 0.0007
376 INTESTINAL MASS 1 0.0007
377 TYPE IV HYPERSENSITIVITY REACTION 2 0.0007
378 HEAD TITUBATION 1 0.0007
379 PROSTATIC DISORDER 4 0.0007
380 DIABETIC METABOLIC DECOMPENSATION 1 0.0007
381 CHRONIC FATIGUE SYNDROME 1 0.0007
382 JOINT INSTABILITY 1 0.0007
383 PRODUCT COMPLAINT 18 0.0007
384 CEREBRAL THROMBOSIS 2 0.0007
385 APPENDIX DISORDER 1 0.0007
386 INSULIN-LIKE GROWTH FACTOR INCREASED 1 0.0007
387 HORDEOLUM 3 0.0007
388 DEAFNESS 18 0.0007
389 LIQUID PRODUCT PHYSICAL ISSUE 5 0.0007
390 CARDIAC FIBRILLATION 1 0.0007
391 DARK CIRCLES UNDER EYES 1 0.0007
392 HEART VALVE REPLACEMENT 1 0.0007
393 CONJUNCTIVITIS ALLERGIC 1 0.0007
394 DRUG EFFECT LESS THAN EXPECTED 10 0.0007
395 PAPILLOEDEMA 3 0.0007
396 ADHESION 1 0.0007
397 NEEDLE ISSUE 19 0.0007
398 ILL-DEFINED DISORDER 39 0.0006
399 HAEMORRHAGIC STROKE 5 0.0006
400 GASTROINTESTINAL STOMA COMPLICATION 1 0.0006
401 ARTERIAL OCCLUSIVE DISEASE 5 0.0006
402 PRODUCT PRESCRIBING ERROR 15 0.0006
403 INTESTINAL ULCER 1 0.0006
404 OCCUPATIONAL EXPOSURE TO PRODUCT 4 0.0006
405 COLON CANCER METASTATIC 1 0.0006
406 HERPES SIMPLEX 4 0.0006
407 ILLUSION 1 0.0006
408 ANTIBODY TEST POSITIVE 1 0.0006
409 HEMIPLEGIA 5 0.0006
410 EYE PRURITUS 20 0.0006
411 HIP FRACTURE 19 0.0006
412 BURNS SECOND DEGREE 1 0.0006
413 CYTOMEGALOVIRUS TEST POSITIVE 1 0.0006
414 JOINT ARTHROPLASTY 1 0.0006
415 RENAL TRANSPLANT 2 0.0006
416 MONOCYTE COUNT INCREASED 2 0.0006
417 DEATH 466 0.0005
418 CEREBRAL DISORDER 4 0.0005
419 CATHETER PLACEMENT 1 0.0005
420 ACCIDENTAL DEATH 1 0.0005
421 RETINOPATHY 2 0.0005
422 IMPAIRED DRIVING ABILITY 6 0.0005
423 CLAVICLE FRACTURE 2 0.0005
424 CERVIX CARCINOMA 2 0.0005
425 DIABETES MELLITUS INADEQUATE CONTROL 9 0.0005
426 CATARACT OPERATION 3 0.0005
427 DEVICE RELATED SEPSIS 1 0.0005
428 CARDIAC DISCOMFORT 1 0.0005
429 PHOTOSENSITIVITY REACTION 8 0.0005
430 BLEPHAROSPASM 3 0.0005
431 CEREBROVASCULAR ACCIDENT 80 0.0005
432 FACIAL PARALYSIS 4 0.0005
433 ENTERITIS 3 0.0005
434 BODY HEIGHT DECREASED 5 0.0005
435 EXOPHTHALMOS 1 0.0005
436 BONE CANCER 2 0.0005
437 BREAST MASS 3 0.0004
438 SUSPECTED OFF LABEL USE 2 0.0004
439 OEDEMA 24 0.0004
440 HAEMATOCRIT INCREASED 1 0.0004
441 EAR DISORDER 2 0.0004
442 HAEMANGIOMA 1 0.0004
443 NEPHROGENIC ANAEMIA 2 0.0004
444 NEPHROPATHY 4 0.0004
445 HAEMORRHAGE 44 0.0004
446 HYPOACUSIS 18 0.0004
447 GASTROINTESTINAL OBSTRUCTION 1 0.0004
448 TRANSIENT ISCHAEMIC ATTACK 14 0.0004
449 PANCREATIC DISORDER 2 0.0004
450 DIABETIC NEUROPATHY 2 0.0004
451 THERAPEUTIC PRODUCT EFFECT DECREASED 18 0.0004
452 ANEURYSM 2 0.0004
453 INJECTION SITE INFLAMMATION 2 0.0004
454 EYELID IRRITATION 1 0.0004
455 CORONARY ARTERY STENOSIS 2 0.0004
456 PRODUCT ADMINISTRATION ERROR 8 0.0004
457 APPENDICITIS PERFORATED 1 0.0004
458 SUBARACHNOID HAEMORRHAGE 4 0.0004
459 ISCHAEMIC STROKE 7 0.0004
460 DRUG DELIVERY SYSTEM MALFUNCTION 2 0.0004
461 MYDRIASIS 5 0.0004
462 PRODUCT PREPARATION ERROR 8 0.0004
463 FOOD ALLERGY 3 0.0004
464 CEREBRAL ISCHAEMIA 2 0.0004
465 ANKLE FRACTURE 6 0.0004
466 CONCUSSION 3 0.0004
467 INJECTION SITE DISCOMFORT 4 0.0004
468 CONJUNCTIVITIS 7 0.0004
469 PRODUCT STORAGE ERROR 33 0.0004
470 ANIMAL BITE 1 0.0004
471 NEOPLASM MALIGNANT 25 0.0004
472 OVERWEIGHT 2 0.0004
473 BREAST SWELLING 1 0.0004
474 ERYTHEMA OF EYELID 2 0.0004
475 EAR CONGESTION 1 0.0004
476 ACUTE CORONARY SYNDROME 3 0.0004
477 PRODUCT PHYSICAL CONSISTENCY ISSUE 2 0.0004
478 CHOLECYSTITIS INFECTIVE 1 0.0004
479 EOSINOPHIL COUNT INCREASED 3 0.0004
480 DUODENAL ULCER HAEMORRHAGE 1 0.0003
481 PARALYSIS 5 0.0003
482 DIPLOPIA 9 0.0003
483 HYPERTONIC BLADDER 1 0.0003
484 EYELID MARGIN CRUSTING 1 0.0003
485 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
486 BILIARY COLIC 1 0.0003
487 GASTROINTESTINAL NECROSIS 1 0.0003
488 SYMPTOM RECURRENCE 2 0.0003
489 THERAPY NON-RESPONDER 15 0.0003
490 HIV INFECTION 1 0.0003
491 ISCHAEMIC CARDIOMYOPATHY 1 0.0003
492 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
493 FLANK PAIN 3 0.0003
494 SPINAL DISORDER 3 0.0003
495 BLADDER PAIN 1 0.0003
496 EXPOSURE TO TOXIC AGENT 1 0.0003
497 VERTIGO 19 0.0003
498 HYPOVENTILATION 1 0.0003
499 DYSGRAPHIA 2 0.0003
500 STAPHYLOCOCCAL INFECTION 10 0.0003
501 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
502 COLITIS ISCHAEMIC 2 0.0003
503 DISCOMFORT 18 0.0003
504 EYE MOVEMENT DISORDER 2 0.0003
505 SCAR 5 0.0003
506 NEPHROTIC SYNDROME 2 0.0003
507 CERVICAL VERTEBRAL FRACTURE 1 0.0003
508 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
509 DRUG INEFFECTIVE 380 0.0003
510 CAROTID ARTERY STENOSIS 1 0.0003
511 MASS 4 0.0003
512 EMBOLIC STROKE 1 0.0003
513 FULL BLOOD COUNT ABNORMAL 3 0.0003
514 FACIAL PARESIS 1 0.0003
515 SEASONAL ALLERGY 4 0.0003
516 HAEMORRHAGIC DIATHESIS 1 0.0003
517 OSTEOMYELITIS 5 0.0003
518 PULMONARY THROMBOSIS 3 0.0003
519 CAROTID ARTERY OCCLUSION 1 0.0003
520 UTERINE LEIOMYOMA 2 0.0003
521 ACUTE MYOCARDIAL INFARCTION 8 0.0003
522 TYPE 2 DIABETES MELLITUS 9 0.0003
523 AUTOIMMUNE THYROIDITIS 1 0.0003
524 FACE INJURY 1 0.0003
525 COMMUNICATION DISORDER 1 0.0003
526 GASTRIC INFECTION 1 0.0003
527 DISSOCIATION 2 0.0003
528 INTERCEPTED PRODUCT ADMINISTRATION ERROR 2 0.0003
529 GINGIVAL DISORDER 1 0.0003
530 ACUTE RESPIRATORY FAILURE 5 0.0003
531 UPPER LIMB FRACTURE 5 0.0003
532 FOREIGN BODY 1 0.0002
533 LOCALISED INFECTION 6 0.0002
534 CYSTITIS HAEMORRHAGIC 1 0.0002
535 STENT PLACEMENT 2 0.0002
536 THERAPEUTIC RESPONSE DECREASED 15 0.0002
537 HYPERURICAEMIA 1 0.0002
538 ANAPHYLACTOID REACTION 1 0.0002
539 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
540 AORTIC DISSECTION 1 0.0002
541 EMBOLISM 2 0.0002
542 SENSATION OF FOREIGN BODY 2 0.0002
543 DIABETES MELLITUS 18 0.0002
544 BLOOD CHOLESTEROL INCREASED 11 0.0002
545 CARDIAC FAILURE CHRONIC 1 0.0002
546 HEPATIC PAIN 1 0.0002
547 PRODUCT CONTAINER ISSUE 2 0.0002
548 CHAPPED LIPS 1 0.0002
549 GRIP STRENGTH DECREASED 2 0.0002
550 INTENTIONAL DEVICE MISUSE 1 0.0002
551 PRODUCT COMMUNICATION ISSUE 2 0.0002
552 PURPURA 2 0.0002
553 HEAD DISCOMFORT 4 0.0002
554 FACIAL PAIN 2 0.0002
555 BRAIN NEOPLASM MALIGNANT 1 0.0002
556 CEREBRAL HAEMORRHAGE 8 0.0002
557 ILLNESS 23 0.0002
558 SINUS CONGESTION 3 0.0002
559 GASTROENTERITIS VIRAL 4 0.0002
560 OPTIC NEURITIS 2 0.0002
561 END STAGE RENAL DISEASE 4 0.0002
562 HAEMOGLOBIN INCREASED 1 0.0002
563 CHRONIC MYELOID LEUKAEMIA 1 0.0002
564 SKIN REACTION 3 0.0002
565 ARTERIOSCLEROSIS 2 0.0002
566 CARDIAC FAILURE 17 0.0002
567 SUBDURAL HAEMATOMA 3 0.0002
568 HYPOVOLAEMIC SHOCK 1 0.0002
569 POST PROCEDURAL COMPLICATION 4 0.0002
570 LOWER LIMB FRACTURE 4 0.0002
571 HUMERUS FRACTURE 1 0.0002
572 AUTOIMMUNE DISORDER 2 0.0002
573 PULMONARY MASS 3 0.0002
574 CORONARY ARTERY DISEASE 6 0.0002
575 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
576 TOOTH ABSCESS 2 0.0002
577 EAR DISCOMFORT 2 0.0002
578 INCREASED UPPER AIRWAY SECRETION 1 0.0002
579 LYMPHOMA 3 0.0002
580 INTENTIONAL PRODUCT USE ISSUE 17 0.0002
581 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
582 RENAL DISORDER 9 0.0002
583 TENDERNESS 2 0.0002
584 KNEE ARTHROPLASTY 4 0.0002
585 SCIATICA 3 0.0002
586 ANORECTAL DISCOMFORT 1 0.0002
587 IMPAIRED WORK ABILITY 4 0.0002
588 DISEASE PROGRESSION 22 0.0002
589 LIMB INJURY 5 0.0002
590 BACK INJURY 2 0.0002
591 HYDROCEPHALUS 1 0.0002
592 BLOOD GLUCOSE FLUCTUATION 2 0.0002
593 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 10 0.0002
594 HYPERKERATOSIS 1 0.0002
595 GASTRIC ULCER HAEMORRHAGE 1 0.0002
596 COAGULOPATHY 3 0.0002
597 INTRACRANIAL PRESSURE INCREASED 1 0.0002
598 HYPERTENSION 38 0.0002
599 INTERMENSTRUAL BLEEDING 1 0.0002
600 CELLULITIS 9 0.0002
601 PANCREATITIS ACUTE 4 0.0002
602 HEMIPARESIS 3 0.0002
603 MYOCARDIAL ISCHAEMIA 2 0.0002
604 HYPERTONIA 1 0.0002
605 NEPHROLITHIASIS 8 0.0002
606 CORONARY ARTERY BYPASS 1 0.0002
607 SWELLING 16 0.0002
608 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
609 BRADYKINESIA 1 0.0002
610 SWELLING FACE 11 0.0002
611 ARRHYTHMIA 8 0.0002
612 FALL 56 0.0002
613 PAIN 103 0.0002
614 ACCIDENT 2 0.0002
615 WRIST FRACTURE 2 0.0002
616 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
617 GANGRENE 1 0.0002
618 BONE DISORDER 3 0.0002
619 INGUINAL HERNIA 1 0.0002
620 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
621 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
622 THROMBOSIS 13 0.0002
623 BACTERIAL INFECTION 3 0.0002
624 INJECTION SITE DISCOLOURATION 2 0.0002
625 DERMATITIS ALLERGIC 2 0.0002
626 FRACTURE 3 0.0002
627 FOOT FRACTURE 3 0.0002
628 PROTEINURIA 3 0.0002
629 RHINORRHOEA 10 0.0002
630 CARDIAC FLUTTER 1 0.0002
631 ATRIAL FIBRILLATION 15 0.0002
632 ANGINA UNSTABLE 1 0.0002
633 AMNESIA 10 0.0002
634 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 31 0.0002
635 SINUS DISORDER 3 0.0002
636 CORONAVIRUS INFECTION 1 0.0002
637 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
638 CARDIAC FAILURE ACUTE 1 0.0001
639 CHOLECYSTITIS CHRONIC 1 0.0001
640 INFARCTION 1 0.0001
641 CORONARY ARTERY OCCLUSION 2 0.0001
642 DELIRIUM 5 0.0001
643 BLOOD PRESSURE INCREASED 22 0.0001
644 MYOCARDIAL INFARCTION 25 0.0001
645 RASH MACULAR 5 0.0001
646 DIALYSIS 2 0.0001
647 PRODUCT QUALITY ISSUE 19 0.0001
648 BREAST CANCER 13 0.0001
649 HERPES ZOSTER 8 0.0001
650 ACCIDENTAL UNDERDOSE 2 0.0001
651 BALANCE DISORDER 12 0.0001
652 DYSSTASIA 4 0.0001
653 FEELING DRUNK 1 0.0001
654 IMMUNODEFICIENCY 2 0.0001
655 HEADACHE 84 0.0001
656 HAEMORRHAGE INTRACRANIAL 2 0.0001
657 SNEEZING 3 0.0001
658 AORTIC ANEURYSM 1 0.0001
659 HAEMODYNAMIC INSTABILITY 1 0.0001
660 EPILEPSY 4 0.0001
661 ACIDOSIS 1 0.0001
662 HIP ARTHROPLASTY 2 0.0001
663 DIZZINESS 65 0.0001
664 BASAL CELL CARCINOMA 2 0.0001
665 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
666 SICKLE CELL ANAEMIA WITH CRISIS 2 0.0001
667 RESPIRATORY TRACT CONGESTION 2 0.0001
668 ULCER 2 0.0001
669 MIGRAINE 12 0.0001
670 GINGIVAL PAIN 1 0.0001
671 MALAISE 55 0.0001
672 ATRIAL FLUTTER 1 0.0001
673 BLOOD GLUCOSE DECREASED 6 0.0001
674 BLOOD DISORDER 1 0.0001
675 NASOPHARYNGITIS 23 0.0001
676 SENSORY DISTURBANCE 2 0.0001
677 FRUSTRATION TOLERANCE DECREASED 1 0.0001
678 MUSCLE TIGHTNESS 2 0.0001
679 HICCUPS 1 0.0001
680 GAIT DISTURBANCE 23 0.0001
681 HAEMODIALYSIS 1 0.0001
682 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
683 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
684 CARDIOVASCULAR DISORDER 3 0.0001
685 CARDIAC DISORDER 11 0.0001
686 INJECTION SITE PAIN 36 0.0001
687 ANAPHYLACTIC SHOCK 3 0.0001
688 CARDIAC OPERATION 1 0.0001
689 EXPOSURE VIA SKIN CONTACT 3 0.0001
690 DEVICE DEFECTIVE 2 0.0001
691 SPEECH DISORDER 6 0.0001
692 JOINT STIFFNESS 3 0.0001
693 DEVICE USE ISSUE 2 0.0001
694 PNEUMONIA 37 0.0001
695 CONTUSION 11 0.0001
696 COVID-19 20 0.0001
697 HEART RATE DECREASED 4 0.0001
698 LYMPHOCYTE COUNT DECREASED 2 0.0001
699 SEIZURE 13 0.0001
700 PULMONARY OEDEMA 5 0.0001
701 PALPITATIONS 13 0.0001
702 MEMORY IMPAIRMENT 15 0.0001
703 BRAIN NEOPLASM 1 0.0001
704 AGRANULOCYTOSIS 2 0.0001
705 WOUND 3 0.0001
706 RENAL IMPAIRMENT 9 0.0001
707 APPENDICITIS 1 0.0001
708 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 5 0.0001
709 EPISTAXIS 8 0.0001
710 PAIN IN JAW 3 0.0001
711 ANGINA PECTORIS 3 0.0001
712 PULMONARY FIBROSIS 2 0.0001
713 HYPERCHOLESTEROLAEMIA 1 0.0001
714 ATELECTASIS 1 0.0001
715 INTERSTITIAL LUNG DISEASE 5 0.0001
716 EAR PAIN 2 0.0001
717 CHOKING 2 0.0001
718 NASAL CONGESTION 6 0.0001
719 HOSPICE CARE 1 0.0001
720 DISORIENTATION 4 0.0001
721 BLADDER DISORDER 1 0.0001
722 RESPIRATORY DISORDER 3 0.0001
723 SPINAL FRACTURE 2 0.0001
724 EMPHYSEMA 1 0.0001
725 EYELID PTOSIS 1 0.0001
726 DRY THROAT 1 0.0001
727 LUNG NEOPLASM MALIGNANT 4 0.0001
728 SWOLLEN TONGUE 3 0.0001
729 URTICARIA 16 0.0001
730 HALLUCINATION, VISUAL 2 0.0001
731 CYSTITIS 3 0.0001
732 HYPOTHYROIDISM 3 0.0001
733 HALLUCINATION 7 0.0001
734 DECREASED ACTIVITY 1 0.0001
735 HYPERSENSITIVITY 17 0.0001
736 GASTROINTESTINAL PAIN 1 0.0001
737 INJECTION SITE NODULE 1 0.0001
738 LIP SWELLING 3 0.0001
739 HYPERTENSIVE CRISIS 1 0.0001
740 INFECTION 13 0.0001
741 ORAL PAIN 2 0.0001
742 DEVICE ISSUE 8 0.0001
743 BLISTER 5 0.0001
744 DERMATITIS CONTACT 1 0.0001
745 INTERNAL HAEMORRHAGE 1 0.0001
746 SHOCK 2 0.0001
747 MUSCLE TWITCHING 2 0.0001
748 EYELID OEDEMA 1 0.0001
749 HYPOXIA 3 0.0001
750 TREATMENT FAILURE 7 0.0001
751 BACTERAEMIA 1 0.0001
752 RENAL FAILURE 11 0.0001
753 MENTAL IMPAIRMENT 2 0.0001
754 BURSITIS 1 0.0001
755 NEURALGIA 2 0.0001
756 CYTOPENIA 1 0.0001
757 INTERCEPTED PRODUCT PREPARATION ERROR 1 0.0001
758 INFLUENZA 9 0.0001
759 CYST 1 0.0001
760 INTESTINAL OBSTRUCTION 3 0.0001
761 CHRONIC KIDNEY DISEASE 6 0.0001
762 INJECTION SITE IRRITATION 1 0.0001
763 DRUG RESISTANCE 2 0.0001
764 ERYTHEMA 16 0.0001
765 SKIN ULCER 2 0.0001
766 ARTHRITIS 6 0.0001
767 URINARY TRACT INFECTION 13 0.0001
768 IMMUNE SYSTEM DISORDER 1 0.0001
769 BLOOD PRESSURE DECREASED 5 0.0001
770 EAR INFECTION 2 0.0001
771 THROAT TIGHTNESS 2 0.0001
772 RASH PRURITIC 4 0.0001
773 OSTEOPOROSIS 3 0.0001
774 INFLUENZA LIKE ILLNESS 6 0.0001
775 CARDIAC ARREST 6 0.0001
776 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 13 0.0001
777 ARTHROPATHY 4 0.0001
778 HAEMOPTYSIS 2 0.0001
779 APHONIA 1 0.0001
780 CARPAL TUNNEL SYNDROME 1 0.0001
781 OSTEOARTHRITIS 3 0.0001
782 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5 0.0001
783 RED BLOOD CELL COUNT DECREASED 2 0.0001
784 ANOSMIA 1 0.0001
785 CONDITION AGGRAVATED 21 0.0001
786 DEVICE DISLOCATION 3 0.0001
787 MENTAL DISORDER 3 0.0001
788 GASTROENTERITIS 1 0.0001
789 DYSPHONIA 4 0.0001
790 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
791 AGITATION 5 0.0001
792 LIVER DISORDER 3 0.0001
793 BRONCHITIS 5 0.0001
794 RENAL INJURY 2 0.0001
795 HYPOAESTHESIA 10 0.0001
796 BLOOD POTASSIUM DECREASED 2 0.0001
797 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
798 INSURANCE ISSUE 1 0.0001
799 TINNITUS 3 0.0001
800 SKIN DISCOLOURATION 3 0.0001
801 DEVICE RELATED INFECTION 1 0.0001
802 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
803 CHEST PAIN 12 0.0001
804 LIMB DISCOMFORT 2 0.0001
805 FEMUR FRACTURE 2 0.0001
806 COGNITIVE DISORDER 3 0.0001
807 ACUTE MYELOID LEUKAEMIA 1 0.0001
808 NERVOUS SYSTEM DISORDER 2 0.0001
809 BRAIN FOG 1 0.0001
810 PULMONARY EMBOLISM 6 0.0001
811 DISEASE RECURRENCE 3 0.0001
812 COMA 3 0.0001
813 PRODUCTIVE COUGH 3 0.0001
814 RASH ERYTHEMATOUS 3 0.0001
815 DRY MOUTH 5 0.0001
816 IMPAIRED HEALING 2 0.0001
817 WEIGHT DECREASED 17 0.0001
818 CYTOMEGALOVIRUS INFECTION 1 0.0001
819 VIRAL INFECTION 2 0.0001
820 ANXIETY 17 0.0001
821 BLOOD UREA INCREASED 1 0.0001
822 DEVICE USE ERROR 2 0.0001
823 NEOPLASM PROGRESSION 2 0.0001
824 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
825 COUGH 16 0.0001
826 DEVICE MALFUNCTION 4 0.0001
827 COLD SWEAT 1 0.0001
828 LYMPHADENOPATHY 2 0.0001
829 GALLBLADDER DISORDER 1 0.0001
830 ASTHENIA 21 0.0001
831 HYPERGLYCAEMIA 2 0.0001
832 PANIC ATTACK 2 0.0001
833 HYPERHIDROSIS 7 0.0001
834 OROPHARYNGEAL PAIN 5 0.0001
835 MEDICATION ERROR 3 0.0001
836 DYSARTHRIA 2 0.0001
837 BLOOD SODIUM DECREASED 1 0.0001
838 ARTHRALGIA 22 0.0001
839 DEPRESSION 12 0.0001
840 BLOOD URINE PRESENT 1 0.0001
841 GASTRIC ULCER 1 0.0001
842 LETHARGY 3 0.0001
843 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
844 DRUG INTOLERANCE 5 0.0001
845 HERNIA 1 0.0001
846 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
847 HAEMORRHOIDS 1 0.0001
848 SURGERY 3 0.0001
849 BLOOD PRESSURE ABNORMAL 1 0.0001
850 INJECTION SITE HAEMORRHAGE 4 0.0001
851 SYNCOPE 5 0.0000
852 CARDIAC FAILURE CONGESTIVE 4 0.0000
853 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
854 STOMATITIS 3 0.0000
855 PSORIATIC ARTHROPATHY 2 0.0000
856 SINUSITIS 5 0.0000
857 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
858 TREMOR 8 0.0000
859 RASH 21 0.0000
860 DERMATITIS 1 0.0000
861 EATING DISORDER 1 0.0000
862 PRURITUS 18 0.0000
863 JOINT INJURY 1 0.0000
864 IRRITABLE BOWEL SYNDROME 1 0.0000
865 DEVICE LEAKAGE 2 0.0000
866 FEELING ABNORMAL 11 0.0000
867 PERIPHERAL SWELLING 7 0.0000
868 DEVICE DIFFICULT TO USE 3 0.0000
869 ANGIOEDEMA 2 0.0000
870 HYPOTENSION 9 0.0000
871 SEPSIS 5 0.0000
872 THROMBOCYTOPENIA 5 0.0000
873 HEART RATE IRREGULAR 1 0.0000
874 PRODUCT DOSE OMISSION ISSUE 13 0.0000
875 MUSCULAR WEAKNESS 5 0.0000
876 SUICIDAL IDEATION 4 0.0000
877 CHILLS 5 0.0000
878 SLEEP DISORDER 3 0.0000
879 NEUROPATHY PERIPHERAL 4 0.0000
880 COLORECTAL CANCER 2 0.0000
881 JOINT SWELLING 5 0.0000
882 HYPOGLYCAEMIA 2 0.0000
883 UNDERDOSE 3 0.0000
884 HEART RATE INCREASED 4 0.0000
885 AGGRESSION 2 0.0000
886 ABDOMINAL PAIN LOWER 1 0.0000
887 GASTRIC CANCER 1 0.0000
888 LOSS OF CONSCIOUSNESS 5 0.0000
889 THERAPY CESSATION 2 0.0000
890 HAEMATOMA 1 0.0000
891 FATIGUE 30 0.0000
892 GASTRITIS 1 0.0000
893 DRUG INTERACTION 6 0.0000
894 PROSTATE CANCER 3 0.0000
895 FEAR 1 0.0000
896 DYSPNOEA 21 0.0000
897 FREQUENT BOWEL MOVEMENTS 1 0.0000
898 BLOOD BILIRUBIN INCREASED 1 0.0000
899 TREATMENT NONCOMPLIANCE 2 0.0000
900 ANAPHYLACTIC REACTION 2 0.0000
901 DIVERTICULITIS 1 0.0000
902 COMPLETED SUICIDE 3 0.0000
903 FEELING COLD 1 0.0000
904 OXYGEN SATURATION DECREASED 2 0.0000
905 ASTHMA 4 0.0000
906 INTENTIONAL DOSE OMISSION 1 0.0000
907 INCORRECT DOSE ADMINISTERED 8 0.0000
908 SOMNOLENCE 7 0.0000
909 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
910 BONE PAIN 2 0.0000
911 VOMITING 16 0.0000
912 ABDOMINAL PAIN UPPER 7 0.0000
913 GASTROINTESTINAL DISORDER 3 0.0000
914 ADVERSE DRUG REACTION 3 0.0000
915 APHASIA 1 0.0000
916 ACUTE KIDNEY INJURY 5 0.0000
917 HOSPITALISATION 5 0.0000
918 EMOTIONAL DISORDER 1 0.0000
919 BLOOD GLUCOSE INCREASED 6 0.0000
920 HEAD INJURY 1 0.0000
921 NAUSEA 25 0.0000
922 CONFUSIONAL STATE 5 0.0000
923 CHOLELITHIASIS 1 0.0000
924 FUNGAL INFECTION 1 0.0000
925 DRY SKIN 4 0.0000
926 GAIT INABILITY 1 0.0000
927 ABDOMINAL DISCOMFORT 5 0.0000
928 ANGER 1 0.0000
929 GASTRIC DISORDER 1 0.0000
930 INJECTION SITE REACTION 2 0.0000
931 ABDOMINAL DISTENSION 3 0.0000
932 BURNING SENSATION 2 0.0000
933 THERAPY INTERRUPTED 2 0.0000
934 MOBILITY DECREASED 2 0.0000
935 CRYING 1 0.0000
936 RESPIRATORY FAILURE 2 0.0000
937 DYSURIA 1 0.0000
938 PAIN IN EXTREMITY 8 0.0000
939 DYSGEUSIA 2 0.0000
940 WEIGHT INCREASED 6 0.0000
941 RHEUMATOID ARTHRITIS 3 0.0000
942 ACNE 2 0.0000
943 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
944 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
945 SKIN EXFOLIATION 2 0.0000
946 MYALGIA 4 0.0000
947 PYREXIA 8 0.0000
948 INTENTIONAL PRODUCT MISUSE 2 0.0000
949 MUSCULOSKELETAL STIFFNESS 2 0.0000
950 COLITIS ULCERATIVE 1 0.0000
951 MUSCLE SPASMS 4 0.0000
952 ADVERSE EVENT 2 0.0000
953 BACK PAIN 5 0.0000
954 FLUID RETENTION 1 0.0000
955 CHEST DISCOMFORT 2 0.0000
956 PARAESTHESIA 3 0.0000
957 DEPRESSED MOOD 1 0.0000
958 INSOMNIA 5 0.0000
959 DISTURBANCE IN ATTENTION 1 0.0000
960 CONSTIPATION 4 0.0000
961 HYPONATRAEMIA 1 0.0000
962 FLATULENCE 1 0.0000
963 DECREASED APPETITE 4 0.0000
964 DIARRHOEA 11 0.0000
965 BLADDER CANCER 1 0.0000
966 EMOTIONAL DISTRESS 2 0.0000
967 OEDEMA PERIPHERAL 2 0.0000
968 FEELING HOT 1 0.0000
969 PRODUCT USE IN UNAPPROVED INDICATION 4 0.0000
970 PRODUCT USE ISSUE 3 0.0000
971 DEEP VEIN THROMBOSIS 1 0.0000
972 BLOOD CREATININE INCREASED 1 0.0000
973 PSORIASIS 2 0.0000
974 ALOPECIA 3 0.0000
975 INFUSION RELATED REACTION 1 0.0000
976 DEHYDRATION 2 0.0000
977 INJURY 1 0.0000
978 HOT FLUSH 1 0.0000
979 ABDOMINAL PAIN 3 0.0000
980 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
981 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
982 TOXICITY TO VARIOUS AGENTS 2 0.0000
983 DYSPHAGIA 1 0.0000
984 ANAEMIA 2 0.0000
985 DYSPEPSIA 1 0.0000
986 FLUSHING 1 0.0000
987 HAEMOGLOBIN DECREASED 1 0.0000
988 INJECTION SITE ERYTHEMA 1 0.0000